cancer trials

cancer trials

featured image of Revolutionary Munich Company Doses First Patient with Groundbreaking Cancer Treatment
Companies

Revolutionary Munich Company Doses First Patient with Groundbreaking Cancer Treatment

BIOT

📢 Tubulis from Munich doses first patient with its ADC candidate TUB-040 targeting NaPi2b antigen in ovarian and lung cancer. 🧪

featured image of Revolutionary AI Platform Speeds Up Cancer Trials
Automation and digitalization

Revolutionary AI Platform Speeds Up Cancer Trials

BIOT

🚀 Paris-based start-up Klineo raises €2m to revolutionize cancer trials, connecting doctors and patients in minutes. 💪🏼🌍

Bioprocessupdates

©2023 - 2026 BioprocessUpdates

PRIVACY POLICY terms of service contact